Skip to main content

12.11.2018 | Original Article

Risk factors for postoperative complications and long-term survival in elderly lung cancer patients: a single institutional experience in Turkey

verfasst von: Celal Bugra Sezen, Anil Gokce, Cem Emrah Kalafat, Cemal Aker, Abdullah Irfan Tastepe

Erschienen in: General Thoracic and Cardiovascular Surgery

Einloggen, um Zugang zu erhalten

Abstract

Background

Lung cancer is a typical disease of elderly patients. While there are many publications in the literature on factors affecting survival, there is still no consensus on the survival impact of lymph node dissection. Our objective in this study was to evaluate prognostic factors influencing rates of complications, mortality, and survival in geriatric patients who underwent surgery for non-small cell lung cancer.

Materials and methods

Data obtained from the medical records of patients aged 70 years or older with early-stage non-small cell lung cancer who underwent surgery between January 01, 2008 and December 31, 2015 were evaluated retrospectively.

Results

Of the 72 patients included, 57 (79.2%) were male and 15 (20.8%) were female. Complications were observed in 42 patients (58.3%). Nineteen patients (26.4%) developed major complications. Percent predicted forced expiratory volume in 1 s (ppFEV1) and age was found to be risk factors for complications. Thirty days days mortality rate was 8.3%. Mortality was not significantly associated with low CCI, physical status, and ppFEV1 values. The 5-year survival rate was 40.5%. ppFEV1 were risk factors affecting survival, whereas radical lymph node dissection was not associated with survival.

Conclusion

The main prognostic factors affecting long-term postoperative survival in the present study was a low postoperative ppFEV1 value. Radical lymph node dissection did not increase the risk of postoperative complications and it did not affect long-term survival in patients aged 70 years or older. A key finding was that comorbidities were not associated with postoperative complications or long-term survival.
Literatur
2.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin Wiley Online Library. 2011;61:69–90.CrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin Wiley Online Library. 2011;61:69–90.CrossRef
3.
Zurück zum Zitat Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJJM. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest Elsevier. 2005;128:237–45.CrossRef Mery CM, Pappas AN, Bueno R, Colson YL, Linden P, Sugarbaker DJJM. Similar long-term survival of elderly patients with non-small cell lung cancer treated with lobectomy or wedge resection within the surveillance, epidemiology, and end results database. Chest Elsevier. 2005;128:237–45.CrossRef
4.
Zurück zum Zitat O’Rourke MA, Feussner JR, Feigl P, Laszlo J. Age trends of lung cancer stage at diagnosis: implications for lung cancer screening in the elderly. JAMA Am Med Assoc. 1987;258:921–6.CrossRef O’Rourke MA, Feussner JR, Feigl P, Laszlo J. Age trends of lung cancer stage at diagnosis: implications for lung cancer screening in the elderly. JAMA Am Med Assoc. 1987;258:921–6.CrossRef
5.
Zurück zum Zitat Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic in longitudinal studies: development. J Chron Dis. 1987;40:373–83.CrossRef Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic in longitudinal studies: development. J Chron Dis. 1987;40:373–83.CrossRef
6.
Zurück zum Zitat Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer. J Thorac Oncol. 2016;11:39–51.CrossRefPubMed Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WEE, et al. The IASLC lung cancer staging project: Proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM Classification for lung cancer. J Thorac Oncol. 2016;11:39–51.CrossRefPubMed
7.
Zurück zum Zitat Eser S, Chang J, Charalambous H, Silverman B, Demetriou A, Yakut C, et al. Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and Izmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program. Turkish J Gastroenterol. 2018;29:35–43.CrossRef Eser S, Chang J, Charalambous H, Silverman B, Demetriou A, Yakut C, et al. Incidence patterns of colorectal cancers in four countries of the Middle East Cancer Consortium (Cyprus, Jordan, Israel, and Izmir, Turkey) compared with those in the United States Surveillance, Epidemiology, and End Results Program. Turkish J Gastroenterol. 2018;29:35–43.CrossRef
12.
Zurück zum Zitat Gonzalez-Aragoneses F, Moreno-Mata N, Simon-Adiego C, Peñalver-Pascual R, Gonzalez-Casaurran G, Perea LA. Lung cancer surgery in the elderly. Crit Rev Oncol Hematol. 2009;71:266–71.CrossRefPubMed Gonzalez-Aragoneses F, Moreno-Mata N, Simon-Adiego C, Peñalver-Pascual R, Gonzalez-Casaurran G, Perea LA. Lung cancer surgery in the elderly. Crit Rev Oncol Hematol. 2009;71:266–71.CrossRefPubMed
13.
Zurück zum Zitat Aoki T, Tsuchida M, Watanabe T, Hashimoto T, Koike T, Hirono T, et al. Surgical strategy for clinical stage I non-small cell lung cancer in octogenarians. Eur J cardio-thoracic Surg. Oxford University Press. 2003;23:446–50.CrossRef Aoki T, Tsuchida M, Watanabe T, Hashimoto T, Koike T, Hirono T, et al. Surgical strategy for clinical stage I non-small cell lung cancer in octogenarians. Eur J cardio-thoracic Surg. Oxford University Press. 2003;23:446–50.CrossRef
14.
Zurück zum Zitat Party BTSS of CS of GBIW. Guidelines on the selection of patients with lung cancer for surgery. Thorax. BMJ Publishing Group Ltd. 2001;56:89–108. Party BTSS of CS of GBIW. Guidelines on the selection of patients with lung cancer for surgery. Thorax. BMJ Publishing Group Ltd. 2001;56:89–108.
15.
Zurück zum Zitat Kobayashi K, Shimizu J, Oda M, Murakami S, Hayashi Y, Ietsugu K, et al. Evaluation of surgical treatment in patients over 80 years of age with lung cancer. Kyobu Geka. 1993;46:103–6.PubMed Kobayashi K, Shimizu J, Oda M, Murakami S, Hayashi Y, Ietsugu K, et al. Evaluation of surgical treatment in patients over 80 years of age with lung cancer. Kyobu Geka. 1993;46:103–6.PubMed
16.
Zurück zum Zitat Chida M, Minowa M, Karube Y, Eba S, Okada Y, Miyoshi S, et al. Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection. Interact Cardiovasc Thorac Surg. Oxford University Press. 2009;8:89–92.CrossRef Chida M, Minowa M, Karube Y, Eba S, Okada Y, Miyoshi S, et al. Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection. Interact Cardiovasc Thorac Surg. Oxford University Press. 2009;8:89–92.CrossRef
17.
Zurück zum Zitat Saji H, Ueno T, Nakamura H, Okumura N, Tsuchida M, Sonobe M, et al. A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303. Eur J Cardio-Thoracic Surg. Oxford University Press. 2017;53:835–41.CrossRef Saji H, Ueno T, Nakamura H, Okumura N, Tsuchida M, Sonobe M, et al. A proposal for a comprehensive risk scoring system for predicting postoperative complications in octogenarian patients with medically operable lung cancer: JACS1303. Eur J Cardio-Thoracic Surg. Oxford University Press. 2017;53:835–41.CrossRef
18.
Zurück zum Zitat Brock MV, Kim MP, Hooker CM, Alberg AJ, Jordan MM, Roig CM, et al. Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience. Ann Thorac Surg Elsevier. 2004;77:271–7.CrossRef Brock MV, Kim MP, Hooker CM, Alberg AJ, Jordan MM, Roig CM, et al. Pulmonary resection in octogenarians with stage I nonsmall cell lung cancer: a 22-year experience. Ann Thorac Surg Elsevier. 2004;77:271–7.CrossRef
19.
Zurück zum Zitat Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC III, Deschamps C, Pairolero PC. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg Elsevier. 2006;82:1175–9.CrossRef Dominguez-Ventura A, Allen MS, Cassivi SD, Nichols FC III, Deschamps C, Pairolero PC. Lung cancer in octogenarians: factors affecting morbidity and mortality after pulmonary resection. Ann Thorac Surg Elsevier. 2006;82:1175–9.CrossRef
20.
Zurück zum Zitat Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, et al. Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years. 2018;53:980–6. Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, et al. Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years. 2018;53:980–6.
21.
Zurück zum Zitat Saji H, Ueno T, Nakamura H. Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303). Gen Thorac Cardiovasc Surg. 2016;10:634–5.CrossRef Saji H, Ueno T, Nakamura H. Prospective observational cohort study of postoperative risk and prognosis scoring for elderly patients with medically operable lung cancer (JACS1303). Gen Thorac Cardiovasc Surg. 2016;10:634–5.CrossRef
22.
Zurück zum Zitat Chida M, Minowa M, Karube Y, Eba S, Okada Y. Institutional report—pulmonary Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection. Interact Cardiovasc Thoracic Surg 2018;8:89–92.CrossRef Chida M, Minowa M, Karube Y, Eba S, Okada Y. Institutional report—pulmonary Worsened long-term outcomes and postoperative complications in octogenarians with lung cancer following mediastinal lymph-node dissection. Interact Cardiovasc Thoracic Surg 2018;8:89–92.CrossRef
23.
Zurück zum Zitat Birim Ö, Zuydendorp HM, Maat APWM, Kappetein AP, Eijkemans MJC, Bogers AJJC. Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg Elsevier. 2003;76:1796–801.CrossRef Birim Ö, Zuydendorp HM, Maat APWM, Kappetein AP, Eijkemans MJC, Bogers AJJC. Lung resection for non-small-cell lung cancer in patients older than 70: mortality, morbidity, and late survival compared with the general population. Ann Thorac Surg Elsevier. 2003;76:1796–801.CrossRef
24.
Zurück zum Zitat Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, et al. Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years. Eur J Cardio-Thoracic Surg. Oxford University Press. 2017;53:980–6.CrossRef Hino H, Karasaki T, Yoshida Y, Fukami T, Sano A, Tanaka M, et al. Risk factors for postoperative complications and long-term survival in lung cancer patients older than 80 years. Eur J Cardio-Thoracic Surg. Oxford University Press. 2017;53:980–6.CrossRef
26.
Zurück zum Zitat Mizushima MDY, Noto MDH, Sugiyama MDS, Kusajima MDY, Yamashita MDR, Kashii MDT, et al. Survival and prognosis after pneumonectomy for lung cancer in the elderly. Ann Thorac Surg Elsevier. 1997;64:193–8.CrossRef Mizushima MDY, Noto MDH, Sugiyama MDS, Kusajima MDY, Yamashita MDR, Kashii MDT, et al. Survival and prognosis after pneumonectomy for lung cancer in the elderly. Ann Thorac Surg Elsevier. 1997;64:193–8.CrossRef
Metadaten
Titel
Risk factors for postoperative complications and long-term survival in elderly lung cancer patients: a single institutional experience in Turkey
verfasst von
Celal Bugra Sezen
Anil Gokce
Cem Emrah Kalafat
Cemal Aker
Abdullah Irfan Tastepe
Publikationsdatum
12.11.2018
Verlag
Springer Singapore
Erschienen in
General Thoracic and Cardiovascular Surgery
Print ISSN: 1863-6705
Elektronische ISSN: 1863-6713
DOI
https://doi.org/10.1007/s11748-018-1031-x

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.